1. Most Discussed
  2. Gainers & Losers

Geneuro announces first patient treated in phase 2A study with GNBAC1 in type 1 diabetes

Bookmark and Share
  1. June 19 (Reuters) - GENEURO SA GNRO.PA :

    • ANNOUNCES FIRST PATIENT TREATED IN PHASE 2A STUDY WITH GNBAC1 IN TYPE 1 DIABETES
    • AUSTRALIAN PHASE 2A CLINICAL STUDY PLANS TO ENROLL 60 ADULT PATIENTS IN OVER 10 CENTERS
    • LAST PATIENT ENROLMENT IS EXPECTED BY END 2017


DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The aim of HotCopper News is to report and comment on news in the financial and investment markets. HotCopper provides no advice on dealing in securities and is not a financial advisor. Professional advice should be sought before making any investment decisions.

Contact editor: editor@hotcopper.com.au

To read reuters' full disclaimer click here
Top